Lisa Brenner
Concepts (498)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Veterans | 130 | 2024 | 1234 | 22.360 |
Why?
| Suicide | 53 | 2024 | 501 | 12.850 |
Why?
| Brain Injuries, Traumatic | 30 | 2024 | 301 | 10.710 |
Why?
| Brain Injuries | 43 | 2024 | 451 | 9.370 |
Why?
| Military Personnel | 37 | 2024 | 525 | 7.570 |
Why?
| Stress Disorders, Post-Traumatic | 38 | 2024 | 759 | 7.160 |
Why?
| Brain Concussion | 22 | 2024 | 471 | 5.940 |
Why?
| Suicidal Ideation | 32 | 2024 | 400 | 5.260 |
Why?
| Suicide, Attempted | 24 | 2024 | 316 | 4.200 |
Why?
| United States Department of Veterans Affairs | 38 | 2024 | 557 | 4.110 |
Why?
| United States | 102 | 2024 | 12297 | 3.320 |
Why?
| Microbiota | 12 | 2024 | 653 | 3.200 |
Why?
| Post-Concussion Syndrome | 10 | 2024 | 155 | 3.160 |
Why?
| Veterans Health | 13 | 2024 | 165 | 3.030 |
Why?
| Mental Health | 17 | 2024 | 571 | 2.920 |
Why?
| Humans | 233 | 2024 | 115611 | 2.460 |
Why?
| Blast Injuries | 8 | 2024 | 43 | 2.410 |
Why?
| Mental Disorders | 16 | 2020 | 902 | 2.360 |
Why?
| Iraq War, 2003-2011 | 19 | 2024 | 151 | 2.280 |
Why?
| Depressive Disorder, Major | 9 | 2024 | 304 | 2.130 |
Why?
| Adult | 107 | 2024 | 30726 | 2.110 |
Why?
| Gastrointestinal Microbiome | 7 | 2023 | 503 | 2.000 |
Why?
| Self-Injurious Behavior | 6 | 2020 | 114 | 1.980 |
Why?
| Middle Aged | 89 | 2024 | 27014 | 1.890 |
Why?
| Male | 122 | 2024 | 55967 | 1.860 |
Why?
| Female | 125 | 2024 | 59931 | 1.770 |
Why?
| Afghan Campaign 2001- | 16 | 2024 | 162 | 1.650 |
Why?
| Occupational Therapy | 2 | 2023 | 73 | 1.590 |
Why?
| Psychological Trauma | 3 | 2022 | 55 | 1.580 |
Why?
| Health Personnel | 3 | 2021 | 582 | 1.470 |
Why?
| Brain Injury, Chronic | 4 | 2016 | 21 | 1.430 |
Why?
| Sleep Wake Disorders | 5 | 2022 | 233 | 1.320 |
Why?
| Social Determinants of Health | 2 | 2023 | 136 | 1.280 |
Why?
| Surveys and Questionnaires | 20 | 2021 | 4668 | 1.280 |
Why?
| Sleep Initiation and Maintenance Disorders | 4 | 2024 | 116 | 1.270 |
Why?
| Psychometrics | 10 | 2022 | 615 | 1.230 |
Why?
| Firearms | 7 | 2023 | 292 | 1.190 |
Why?
| Mental Health Services | 9 | 2024 | 326 | 1.150 |
Why?
| Young Adult | 41 | 2024 | 10487 | 1.150 |
Why?
| Qualitative Research | 10 | 2024 | 975 | 1.140 |
Why?
| Depressive Disorder | 5 | 2024 | 336 | 1.140 |
Why?
| Aged | 44 | 2024 | 19255 | 1.110 |
Why?
| Health Promotion | 5 | 2019 | 693 | 1.050 |
Why?
| Cross-Sectional Studies | 22 | 2024 | 4438 | 1.040 |
Why?
| Hyperbaric Oxygenation | 3 | 2015 | 37 | 1.030 |
Why?
| Pandemics | 5 | 2023 | 1334 | 1.020 |
Why?
| Violence | 5 | 2023 | 202 | 0.990 |
Why?
| Aftercare | 3 | 2021 | 187 | 0.990 |
Why?
| Severity of Illness Index | 14 | 2021 | 2578 | 0.950 |
Why?
| Health Services Accessibility | 5 | 2020 | 772 | 0.930 |
Why?
| Toxoplasmosis | 6 | 2024 | 31 | 0.920 |
Why?
| Substance-Related Disorders | 5 | 2023 | 951 | 0.860 |
Why?
| Transition to Adult Care | 1 | 2024 | 62 | 0.860 |
Why?
| Physical Therapy Specialty | 1 | 2023 | 34 | 0.830 |
Why?
| Cerebral Palsy | 1 | 2024 | 80 | 0.830 |
Why?
| Head Injuries, Closed | 1 | 2022 | 48 | 0.820 |
Why?
| Evidence-Based Medicine | 3 | 2023 | 684 | 0.810 |
Why?
| Patient Discharge | 5 | 2021 | 770 | 0.800 |
Why?
| Drug Overdose | 2 | 2023 | 296 | 0.800 |
Why?
| Mass Screening | 8 | 2024 | 1024 | 0.800 |
Why?
| Toxoplasma | 5 | 2024 | 33 | 0.790 |
Why?
| Cohort Studies | 16 | 2021 | 4945 | 0.790 |
Why?
| Nutritional Status | 1 | 2024 | 289 | 0.780 |
Why?
| Personality Assessment | 4 | 2017 | 79 | 0.780 |
Why?
| Occupational Diseases | 2 | 2020 | 129 | 0.760 |
Why?
| Longitudinal Studies | 13 | 2024 | 2420 | 0.760 |
Why?
| Retrospective Studies | 20 | 2024 | 12608 | 0.760 |
Why?
| Air Pollutants | 1 | 2024 | 246 | 0.730 |
Why?
| Stroke Rehabilitation | 1 | 2021 | 34 | 0.730 |
Why?
| Risk Factors | 31 | 2024 | 8699 | 0.730 |
Why?
| Adaptation, Psychological | 7 | 2018 | 551 | 0.730 |
Why?
| Spinal Cord Injuries | 2 | 2022 | 173 | 0.720 |
Why?
| Models, Psychological | 1 | 2022 | 299 | 0.700 |
Why?
| Dysbiosis | 2 | 2018 | 146 | 0.690 |
Why?
| Disability Evaluation | 6 | 2019 | 271 | 0.690 |
Why?
| Psychotherapy | 2 | 2017 | 149 | 0.650 |
Why?
| Safety | 2 | 2020 | 298 | 0.630 |
Why?
| Animal Assisted Therapy | 1 | 2018 | 9 | 0.630 |
Why?
| Parkinson Disease | 1 | 2022 | 325 | 0.630 |
Why?
| Pets | 1 | 2018 | 20 | 0.630 |
Why?
| Wounds, Gunshot | 5 | 2023 | 187 | 0.630 |
Why?
| Child Development | 1 | 2022 | 389 | 0.620 |
Why?
| Death Certificates | 2 | 2023 | 30 | 0.620 |
Why?
| Mobile Applications | 1 | 2020 | 140 | 0.620 |
Why?
| Neuropsychological Tests | 7 | 2020 | 920 | 0.620 |
Why?
| Hope | 1 | 2018 | 12 | 0.610 |
Why?
| Sense of Coherence | 1 | 2018 | 14 | 0.610 |
Why?
| Triage | 1 | 2020 | 192 | 0.610 |
Why?
| Hospitals, Veterans | 7 | 2022 | 245 | 0.590 |
Why?
| Risk Assessment | 16 | 2024 | 2987 | 0.590 |
Why?
| Child Abuse | 1 | 2022 | 455 | 0.590 |
Why?
| Caregivers | 1 | 2024 | 716 | 0.580 |
Why?
| Risk | 5 | 2023 | 819 | 0.570 |
Why?
| Drug Packaging | 1 | 2017 | 43 | 0.570 |
Why?
| Inflammation | 7 | 2022 | 2499 | 0.570 |
Why?
| Psychotherapy, Group | 1 | 2017 | 61 | 0.560 |
Why?
| Executive Function | 4 | 2017 | 373 | 0.560 |
Why?
| Probiotics | 1 | 2017 | 47 | 0.560 |
Why?
| Cognition Disorders | 3 | 2014 | 475 | 0.560 |
Why?
| Patient Care Team | 3 | 2024 | 521 | 0.550 |
Why?
| Outpatients | 2 | 2023 | 330 | 0.540 |
Why?
| Home Care Services | 1 | 2019 | 226 | 0.540 |
Why?
| Multiple Trauma | 2 | 2024 | 90 | 0.540 |
Why?
| Protective Factors | 2 | 2015 | 87 | 0.540 |
Why?
| Feasibility Studies | 5 | 2021 | 741 | 0.540 |
Why?
| Hospitalization | 5 | 2019 | 1765 | 0.540 |
Why?
| Problem Solving | 1 | 2017 | 141 | 0.540 |
Why?
| Postural Balance | 1 | 2018 | 182 | 0.540 |
Why?
| Cause of Death | 2 | 2023 | 368 | 0.520 |
Why?
| Headache | 3 | 2022 | 131 | 0.520 |
Why?
| Feces | 3 | 2024 | 372 | 0.510 |
Why?
| Adolescent | 18 | 2024 | 17903 | 0.500 |
Why?
| Pneumonia, Viral | 1 | 2020 | 344 | 0.490 |
Why?
| Coronavirus Infections | 1 | 2020 | 336 | 0.490 |
Why?
| Self Report | 5 | 2017 | 698 | 0.480 |
Why?
| Quality Improvement | 2 | 2020 | 958 | 0.480 |
Why?
| Antidepressive Agents | 4 | 2024 | 195 | 0.470 |
Why?
| Combat Disorders | 2 | 2017 | 33 | 0.470 |
Why?
| Hypertension | 1 | 2022 | 1064 | 0.470 |
Why?
| Afghanistan | 3 | 2024 | 108 | 0.470 |
Why?
| Case-Control Studies | 8 | 2022 | 3023 | 0.460 |
Why?
| Comorbidity | 9 | 2022 | 1473 | 0.460 |
Why?
| Disabled Persons | 2 | 2012 | 135 | 0.450 |
Why?
| Neuropsychology | 2 | 2011 | 32 | 0.440 |
Why?
| Patient Acceptance of Health Care | 3 | 2024 | 683 | 0.440 |
Why?
| Health Planning | 1 | 2013 | 46 | 0.440 |
Why?
| Athletic Injuries | 1 | 2019 | 457 | 0.440 |
Why?
| Emotions | 1 | 2018 | 477 | 0.430 |
Why?
| Inpatients | 3 | 2014 | 380 | 0.430 |
Why?
| Iraq | 2 | 2024 | 81 | 0.430 |
Why?
| Social Support | 5 | 2024 | 539 | 0.430 |
Why?
| Risk Management | 1 | 2014 | 89 | 0.430 |
Why?
| Anxiety Disorders | 1 | 2016 | 310 | 0.430 |
Why?
| Medication Adherence | 1 | 2017 | 538 | 0.420 |
Why?
| Impulsive Behavior | 4 | 2024 | 109 | 0.420 |
Why?
| Observational Studies as Topic | 2 | 2024 | 89 | 0.420 |
Why?
| Quality of Life | 5 | 2019 | 2387 | 0.410 |
Why?
| Trauma Severity Indices | 5 | 2019 | 111 | 0.410 |
Why?
| Interpersonal Relations | 1 | 2015 | 342 | 0.410 |
Why?
| Psychiatric Status Rating Scales | 6 | 2018 | 485 | 0.400 |
Why?
| Telemedicine | 1 | 2020 | 667 | 0.400 |
Why?
| Stress, Physiological | 1 | 2015 | 399 | 0.400 |
Why?
| Attitude of Health Personnel | 2 | 2016 | 990 | 0.400 |
Why?
| Aged, 80 and over | 7 | 2021 | 6419 | 0.390 |
Why?
| Colorado | 6 | 2024 | 4116 | 0.390 |
Why?
| Ambulatory Care | 3 | 2018 | 479 | 0.390 |
Why?
| Antibodies, Protozoan | 4 | 2024 | 29 | 0.380 |
Why?
| Porphyromonas gingivalis | 2 | 2022 | 17 | 0.370 |
Why?
| Depression | 4 | 2024 | 1147 | 0.370 |
Why?
| Socioeconomic Factors | 6 | 2023 | 1086 | 0.370 |
Why?
| Sleep Apnea, Obstructive | 2 | 2024 | 194 | 0.370 |
Why?
| Ethanol | 3 | 2024 | 549 | 0.370 |
Why?
| Bayes Theorem | 2 | 2022 | 334 | 0.360 |
Why?
| Wounds and Injuries | 1 | 2018 | 725 | 0.360 |
Why?
| Post-Traumatic Headache | 2 | 2020 | 3 | 0.360 |
Why?
| Reproducibility of Results | 9 | 2022 | 2800 | 0.360 |
Why?
| Sex Offenses | 2 | 2023 | 148 | 0.350 |
Why?
| Tryptophan | 3 | 2022 | 136 | 0.350 |
Why?
| Terminology as Topic | 1 | 2011 | 186 | 0.350 |
Why?
| Prevalence | 8 | 2022 | 2265 | 0.340 |
Why?
| Sleep | 3 | 2024 | 625 | 0.330 |
Why?
| Public Health | 5 | 2022 | 438 | 0.330 |
Why?
| Crisis Intervention | 3 | 2024 | 30 | 0.330 |
Why?
| Diagnostic Imaging | 2 | 2011 | 296 | 0.320 |
Why?
| Cognitive Dysfunction | 1 | 2013 | 279 | 0.320 |
Why?
| Quality of Health Care | 1 | 2013 | 576 | 0.320 |
Why?
| Dizziness | 2 | 2019 | 70 | 0.320 |
Why?
| Amish | 2 | 2019 | 7 | 0.320 |
Why?
| Housing | 2 | 2020 | 114 | 0.320 |
Why?
| Stress, Psychological | 2 | 2020 | 975 | 0.310 |
Why?
| Program Evaluation | 3 | 2024 | 836 | 0.310 |
Why?
| Intention | 1 | 2009 | 143 | 0.310 |
Why?
| Immunoglobulin G | 5 | 2024 | 781 | 0.300 |
Why?
| Kynurenine | 3 | 2018 | 80 | 0.290 |
Why?
| Neuropsychiatry | 2 | 2020 | 15 | 0.280 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2024 | 1218 | 0.280 |
Why?
| Health Behavior | 1 | 2012 | 707 | 0.280 |
Why?
| Emergency Service, Hospital | 6 | 2020 | 1829 | 0.280 |
Why?
| Emergency Medical Services | 2 | 2023 | 590 | 0.270 |
Why?
| Follow-Up Studies | 5 | 2022 | 4440 | 0.270 |
Why?
| Environment, Controlled | 2 | 2016 | 19 | 0.270 |
Why?
| Recovery of Function | 4 | 2019 | 577 | 0.270 |
Why?
| Time Factors | 6 | 2019 | 6165 | 0.270 |
Why?
| Treatment Outcome | 10 | 2022 | 9159 | 0.270 |
Why?
| Hotlines | 4 | 2024 | 29 | 0.260 |
Why?
| Motivation | 1 | 2009 | 498 | 0.250 |
Why?
| Prospective Studies | 9 | 2022 | 6264 | 0.250 |
Why?
| Rehabilitation Centers | 2 | 2024 | 32 | 0.250 |
Why?
| Affect | 2 | 2018 | 244 | 0.250 |
Why?
| Complementary Therapies | 2 | 2016 | 73 | 0.240 |
Why?
| Lomustine | 1 | 2024 | 14 | 0.230 |
Why?
| Policy | 2 | 2022 | 140 | 0.230 |
Why?
| Sensitivity and Specificity | 4 | 2013 | 1718 | 0.230 |
Why?
| Metals, Heavy | 1 | 2024 | 19 | 0.230 |
Why?
| Wildfires | 1 | 2024 | 18 | 0.230 |
Why?
| Sex Distribution | 2 | 2023 | 337 | 0.230 |
Why?
| Pesticides | 1 | 2024 | 49 | 0.220 |
Why?
| Irritable Bowel Syndrome | 1 | 2023 | 29 | 0.220 |
Why?
| RNA, Ribosomal, 16S | 3 | 2020 | 489 | 0.220 |
Why?
| Clinical Protocols | 2 | 2015 | 233 | 0.220 |
Why?
| Global Burden of Disease | 1 | 2023 | 15 | 0.220 |
Why?
| Transportation of Patients | 1 | 2023 | 52 | 0.220 |
Why?
| Psychiatric Department, Hospital | 2 | 2014 | 15 | 0.220 |
Why?
| Prednisone | 1 | 2024 | 232 | 0.220 |
Why?
| Disaster Planning | 1 | 2024 | 77 | 0.210 |
Why?
| Abruptio Placentae | 1 | 2022 | 3 | 0.210 |
Why?
| Disasters | 1 | 2024 | 88 | 0.210 |
Why?
| Interview, Psychological | 2 | 2015 | 91 | 0.210 |
Why?
| Factor Analysis, Statistical | 3 | 2018 | 261 | 0.210 |
Why?
| Aggression | 4 | 2021 | 185 | 0.210 |
Why?
| Incidence | 6 | 2019 | 2335 | 0.200 |
Why?
| Ohio | 1 | 2022 | 136 | 0.200 |
Why?
| Pharmacogenomic Testing | 1 | 2022 | 54 | 0.200 |
Why?
| Logistic Models | 6 | 2019 | 1856 | 0.200 |
Why?
| Inappropriate Prescribing | 1 | 2022 | 52 | 0.200 |
Why?
| Schizophrenia | 2 | 2016 | 418 | 0.200 |
Why?
| Health Knowledge, Attitudes, Practice | 2 | 2024 | 1200 | 0.200 |
Why?
| Air Pollution | 1 | 2024 | 172 | 0.190 |
Why?
| Meta-Analysis as Topic | 1 | 2022 | 161 | 0.190 |
Why?
| Neopterin | 2 | 2022 | 9 | 0.190 |
Why?
| HIV Infections | 1 | 2015 | 2473 | 0.190 |
Why?
| Subacute Care | 1 | 2022 | 70 | 0.190 |
Why?
| Frailty | 1 | 2024 | 116 | 0.190 |
Why?
| Skin | 2 | 2023 | 662 | 0.190 |
Why?
| Cost of Illness | 1 | 2023 | 257 | 0.190 |
Why?
| Hepatic Encephalopathy | 1 | 2021 | 21 | 0.190 |
Why?
| Drug Interactions | 1 | 2022 | 347 | 0.190 |
Why?
| Skilled Nursing Facilities | 1 | 2022 | 119 | 0.180 |
Why?
| Anger | 3 | 2021 | 55 | 0.180 |
Why?
| Environmental Exposure | 1 | 2024 | 378 | 0.180 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2021 | 61 | 0.180 |
Why?
| Sex Factors | 6 | 2024 | 1737 | 0.180 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 4 | 2016 | 230 | 0.180 |
Why?
| Seasonal Affective Disorder | 1 | 2020 | 9 | 0.170 |
Why?
| Communicable Diseases | 1 | 2022 | 130 | 0.170 |
Why?
| Hyperacusis | 1 | 2019 | 8 | 0.170 |
Why?
| Photophobia | 1 | 2019 | 10 | 0.170 |
Why?
| Receptors, Calcitriol | 1 | 2020 | 53 | 0.170 |
Why?
| Survival Analysis | 3 | 2011 | 1219 | 0.170 |
Why?
| Vitamin D Deficiency | 1 | 2021 | 159 | 0.170 |
Why?
| Hypesthesia | 1 | 2019 | 16 | 0.170 |
Why?
| Health Services Needs and Demand | 1 | 2021 | 249 | 0.170 |
Why?
| Environment Design | 2 | 2016 | 24 | 0.170 |
Why?
| Morals | 1 | 2020 | 65 | 0.170 |
Why?
| Periodontitis | 1 | 2020 | 42 | 0.170 |
Why?
| Inflammatory Bowel Diseases | 1 | 2023 | 289 | 0.170 |
Why?
| Paresis | 1 | 2019 | 28 | 0.170 |
Why?
| Alcoholism | 2 | 2024 | 717 | 0.170 |
Why?
| Arm Injuries | 1 | 2019 | 23 | 0.170 |
Why?
| Chronic Traumatic Encephalopathy | 1 | 2019 | 14 | 0.170 |
Why?
| Premature Birth | 1 | 2022 | 278 | 0.160 |
Why?
| Delirium | 2 | 2011 | 66 | 0.160 |
Why?
| Diet | 2 | 2023 | 1072 | 0.160 |
Why?
| Odds Ratio | 5 | 2016 | 962 | 0.160 |
Why?
| Fatigue | 2 | 2018 | 296 | 0.160 |
Why?
| Cross-Over Studies | 2 | 2018 | 434 | 0.160 |
Why?
| Medical Staff, Hospital | 1 | 2019 | 74 | 0.160 |
Why?
| Liver Cirrhosis | 1 | 2021 | 238 | 0.160 |
Why?
| Environmental Microbiology | 1 | 2019 | 43 | 0.160 |
Why?
| Occupational Injuries | 1 | 2019 | 46 | 0.160 |
Why?
| Patient-Centered Care | 1 | 2024 | 477 | 0.160 |
Why?
| Women's Health | 1 | 2021 | 271 | 0.160 |
Why?
| Arm | 1 | 2019 | 105 | 0.160 |
Why?
| Psychotherapy, Brief | 1 | 2018 | 30 | 0.160 |
Why?
| Food Supply | 1 | 2019 | 66 | 0.160 |
Why?
| Adiponectin | 1 | 2020 | 214 | 0.150 |
Why?
| Pilot Projects | 4 | 2017 | 1377 | 0.150 |
Why?
| Health Services Research | 1 | 2021 | 377 | 0.150 |
Why?
| Phenylalanine | 1 | 2018 | 58 | 0.150 |
Why?
| Dogs | 1 | 2018 | 341 | 0.150 |
Why?
| Age Factors | 5 | 2019 | 2907 | 0.140 |
Why?
| Disease Models, Animal | 2 | 2017 | 3580 | 0.140 |
Why?
| Prefrontal Cortex | 2 | 2017 | 267 | 0.140 |
Why?
| Tyrosine | 1 | 2018 | 219 | 0.140 |
Why?
| Prebiotics | 1 | 2017 | 23 | 0.140 |
Why?
| Databases, Factual | 1 | 2022 | 1138 | 0.140 |
Why?
| Confidence Intervals | 3 | 2016 | 309 | 0.140 |
Why?
| Gliadin | 1 | 2016 | 12 | 0.140 |
Why?
| Rural Population | 1 | 2020 | 448 | 0.140 |
Why?
| Patient Selection | 1 | 2020 | 654 | 0.140 |
Why?
| Obesity | 2 | 2019 | 2517 | 0.140 |
Why?
| Amygdala | 2 | 2017 | 179 | 0.140 |
Why?
| Nervous System Diseases | 1 | 2019 | 253 | 0.130 |
Why?
| Physical Therapy Modalities | 1 | 2019 | 269 | 0.130 |
Why?
| Housing, Animal | 1 | 2016 | 45 | 0.130 |
Why?
| Perception | 2 | 2019 | 315 | 0.130 |
Why?
| Social Work, Psychiatric | 1 | 2015 | 3 | 0.130 |
Why?
| Immunomodulation | 1 | 2016 | 85 | 0.130 |
Why?
| Neuroimaging | 2 | 2017 | 248 | 0.130 |
Why?
| Community Mental Health Centers | 1 | 2015 | 13 | 0.130 |
Why?
| Actigraphy | 1 | 2016 | 73 | 0.130 |
Why?
| Analgesics, Opioid | 1 | 2023 | 783 | 0.130 |
Why?
| Counseling | 2 | 2023 | 347 | 0.130 |
Why?
| Medical Records | 1 | 2016 | 157 | 0.130 |
Why?
| Prescription Drug Misuse | 1 | 2015 | 38 | 0.130 |
Why?
| Delivery of Health Care | 4 | 2023 | 844 | 0.120 |
Why?
| Burnout, Professional | 1 | 2020 | 322 | 0.120 |
Why?
| Health Status Indicators | 2 | 2012 | 155 | 0.120 |
Why?
| Thalamus | 1 | 2015 | 78 | 0.120 |
Why?
| Propylamines | 1 | 2014 | 11 | 0.120 |
Why?
| Adrenergic Uptake Inhibitors | 1 | 2014 | 13 | 0.120 |
Why?
| Biomedical Research | 1 | 2020 | 588 | 0.120 |
Why?
| Mood Disorders | 1 | 2015 | 117 | 0.120 |
Why?
| Analgesics | 1 | 2015 | 157 | 0.120 |
Why?
| Forecasting | 1 | 2016 | 333 | 0.120 |
Why?
| Cross-Cultural Comparison | 1 | 2014 | 77 | 0.120 |
Why?
| Interviews as Topic | 4 | 2018 | 597 | 0.110 |
Why?
| Cerebellum | 1 | 2015 | 200 | 0.110 |
Why?
| Self Concept | 1 | 2015 | 218 | 0.110 |
Why?
| Australia | 1 | 2014 | 207 | 0.110 |
Why?
| Forensic Psychiatry | 1 | 2013 | 25 | 0.110 |
Why?
| Percutaneous Coronary Intervention | 1 | 2019 | 445 | 0.110 |
Why?
| Patient Satisfaction | 1 | 2017 | 585 | 0.110 |
Why?
| Employment | 1 | 2014 | 139 | 0.110 |
Why?
| Seroepidemiologic Studies | 3 | 2019 | 140 | 0.110 |
Why?
| Chi-Square Distribution | 2 | 2011 | 499 | 0.110 |
Why?
| Hawaii | 2 | 2024 | 38 | 0.110 |
Why?
| Coronary Artery Disease | 1 | 2019 | 607 | 0.110 |
Why?
| Stress Disorders, Traumatic | 1 | 2013 | 23 | 0.110 |
Why?
| Linear Models | 3 | 2010 | 776 | 0.110 |
Why?
| Sex | 1 | 2012 | 2 | 0.110 |
Why?
| Infant | 2 | 2022 | 7975 | 0.110 |
Why?
| Multivariate Analysis | 2 | 2019 | 1440 | 0.100 |
Why?
| Social Stigma | 1 | 2013 | 88 | 0.100 |
Why?
| Football | 1 | 2013 | 77 | 0.100 |
Why?
| Algorithms | 3 | 2019 | 1490 | 0.100 |
Why?
| Advisory Committees | 1 | 2013 | 208 | 0.100 |
Why?
| Computer Communication Networks | 1 | 2012 | 32 | 0.100 |
Why?
| Decision Making | 2 | 2017 | 791 | 0.100 |
Why?
| Reproductive Health | 2 | 2023 | 70 | 0.100 |
Why?
| Task Performance and Analysis | 2 | 2017 | 160 | 0.100 |
Why?
| Walking | 1 | 2015 | 425 | 0.100 |
Why?
| Therapy, Computer-Assisted | 1 | 2012 | 58 | 0.100 |
Why?
| Child | 4 | 2023 | 18486 | 0.100 |
Why?
| Information Dissemination | 1 | 2013 | 193 | 0.100 |
Why?
| Prognosis | 2 | 2017 | 3339 | 0.100 |
Why?
| Statistics, Nonparametric | 2 | 2009 | 390 | 0.100 |
Why?
| Interprofessional Relations | 1 | 2013 | 258 | 0.090 |
Why?
| United States Department of Defense | 1 | 2011 | 15 | 0.090 |
Why?
| Consciousness Disorders | 1 | 2011 | 19 | 0.090 |
Why?
| Ethics, Professional | 1 | 2011 | 15 | 0.090 |
Why?
| Life Change Events | 1 | 2012 | 135 | 0.090 |
Why?
| Predictive Value of Tests | 2 | 2019 | 1805 | 0.090 |
Why?
| Brain | 3 | 2021 | 2373 | 0.090 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 85 | 0.090 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 362 | 0.090 |
Why?
| Multiple Sclerosis | 1 | 2015 | 380 | 0.090 |
Why?
| Psychomotor Agitation | 1 | 2011 | 66 | 0.090 |
Why?
| Glucose | 1 | 2015 | 904 | 0.090 |
Why?
| Health Policy | 1 | 2013 | 334 | 0.090 |
Why?
| Inservice Training | 1 | 2011 | 107 | 0.090 |
Why?
| Life Style | 1 | 2012 | 429 | 0.090 |
Why?
| Research | 1 | 2013 | 396 | 0.090 |
Why?
| Anxiety | 3 | 2024 | 854 | 0.090 |
Why?
| Health Plan Implementation | 1 | 2011 | 133 | 0.090 |
Why?
| HIV-1 | 1 | 2015 | 771 | 0.090 |
Why?
| Interdisciplinary Communication | 1 | 2011 | 185 | 0.090 |
Why?
| Elective Surgical Procedures | 1 | 2011 | 154 | 0.090 |
Why?
| Irritable Mood | 2 | 2021 | 48 | 0.090 |
Why?
| Diagnosis, Differential | 1 | 2014 | 1357 | 0.090 |
Why?
| Explosions | 1 | 2009 | 11 | 0.090 |
Why?
| Religion and Psychology | 1 | 2009 | 25 | 0.090 |
Why?
| Analysis of Variance | 2 | 2011 | 1227 | 0.090 |
Why?
| Patient Education as Topic | 1 | 2014 | 686 | 0.080 |
Why?
| Affective Symptoms | 1 | 2009 | 49 | 0.080 |
Why?
| Data Collection | 1 | 2012 | 636 | 0.080 |
Why?
| Alcohol Drinking | 1 | 2014 | 650 | 0.080 |
Why?
| Neurologic Examination | 1 | 2009 | 116 | 0.080 |
Why?
| Hypogonadism | 1 | 2009 | 74 | 0.080 |
Why?
| Cooperative Behavior | 1 | 2011 | 390 | 0.080 |
Why?
| Population Surveillance | 1 | 2011 | 395 | 0.080 |
Why?
| Proportional Hazards Models | 1 | 2011 | 1087 | 0.080 |
Why?
| Resilience, Psychological | 1 | 2009 | 98 | 0.080 |
Why?
| Needs Assessment | 1 | 2009 | 318 | 0.070 |
Why?
| Decision Support Techniques | 1 | 2011 | 353 | 0.070 |
Why?
| Glasgow Coma Scale | 3 | 2014 | 144 | 0.070 |
Why?
| Brain Mapping | 1 | 2011 | 521 | 0.070 |
Why?
| Aging | 1 | 2017 | 1631 | 0.070 |
Why?
| Language Disorders | 1 | 2007 | 32 | 0.070 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 795 | 0.070 |
Why?
| Psychological Tests | 1 | 2007 | 123 | 0.070 |
Why?
| Animals | 5 | 2018 | 32102 | 0.070 |
Why?
| Healthy Volunteers | 2 | 2018 | 192 | 0.070 |
Why?
| Testosterone | 1 | 2009 | 337 | 0.060 |
Why?
| Machine Learning | 2 | 2021 | 321 | 0.060 |
Why?
| Length of Stay | 1 | 2009 | 958 | 0.060 |
Why?
| Cognition | 2 | 2022 | 981 | 0.060 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1361 | 0.060 |
Why?
| Social Change | 1 | 2024 | 12 | 0.060 |
Why?
| Treatment Adherence and Compliance | 1 | 2024 | 18 | 0.060 |
Why?
| Biomarkers | 2 | 2024 | 3467 | 0.060 |
Why?
| Asphyxia | 1 | 2023 | 21 | 0.060 |
Why?
| Friends | 1 | 2023 | 46 | 0.050 |
Why?
| Guam | 1 | 2023 | 7 | 0.050 |
Why?
| Immunoglobulin M | 1 | 2024 | 254 | 0.050 |
Why?
| Stillbirth | 1 | 2022 | 57 | 0.050 |
Why?
| Public Opinion | 1 | 2022 | 59 | 0.050 |
Why?
| Ownership | 1 | 2022 | 81 | 0.050 |
Why?
| Postoperative Complications | 2 | 2011 | 2161 | 0.050 |
Why?
| Remission Induction | 1 | 2022 | 240 | 0.050 |
Why?
| Social Justice | 1 | 2022 | 66 | 0.050 |
Why?
| Pregnancy Trimester, First | 1 | 2022 | 127 | 0.050 |
Why?
| Disease Susceptibility | 1 | 2023 | 316 | 0.050 |
Why?
| Pharmacogenetics | 1 | 2022 | 151 | 0.050 |
Why?
| Nursing Homes | 1 | 2022 | 136 | 0.050 |
Why?
| Breast Neoplasms | 1 | 2012 | 1872 | 0.050 |
Why?
| Pregnancy | 2 | 2022 | 5550 | 0.040 |
Why?
| Research Report | 1 | 2021 | 76 | 0.040 |
Why?
| Double-Blind Method | 2 | 2015 | 1659 | 0.040 |
Why?
| Cathelicidins | 1 | 2020 | 39 | 0.040 |
Why?
| Patient Compliance | 1 | 2024 | 524 | 0.040 |
Why?
| Lithium Compounds | 1 | 2019 | 9 | 0.040 |
Why?
| Clinical Decision-Making | 1 | 2022 | 273 | 0.040 |
Why?
| Central Nervous System | 1 | 2021 | 239 | 0.040 |
Why?
| Antimicrobial Cationic Peptides | 1 | 2020 | 76 | 0.040 |
Why?
| Disease Progression | 2 | 2017 | 2418 | 0.040 |
Why?
| September 11 Terrorist Attacks | 1 | 2019 | 22 | 0.040 |
Why?
| Retirement | 1 | 2019 | 25 | 0.040 |
Why?
| Research Design | 2 | 2015 | 946 | 0.040 |
Why?
| Wakefulness | 1 | 2019 | 128 | 0.040 |
Why?
| Patient Preference | 1 | 2020 | 171 | 0.040 |
Why?
| Ketamine | 1 | 2019 | 92 | 0.040 |
Why?
| Attitude | 1 | 2020 | 229 | 0.040 |
Why?
| Serologic Tests | 1 | 2018 | 51 | 0.040 |
Why?
| Epigenesis, Genetic | 1 | 2022 | 526 | 0.040 |
Why?
| Germany | 1 | 2018 | 86 | 0.040 |
Why?
| Magnetic Resonance Imaging | 1 | 2009 | 3071 | 0.040 |
Why?
| Memory Disorders | 1 | 2019 | 155 | 0.040 |
Why?
| Nutrition Surveys | 1 | 2019 | 225 | 0.040 |
Why?
| Referral and Consultation | 1 | 2022 | 646 | 0.040 |
Why?
| Seasons | 1 | 2020 | 449 | 0.040 |
Why?
| Behavior Therapy | 1 | 2019 | 225 | 0.040 |
Why?
| Placenta | 1 | 2022 | 624 | 0.030 |
Why?
| Behavioral Risk Factor Surveillance System | 1 | 2016 | 44 | 0.030 |
Why?
| RNA, Bacterial | 1 | 2017 | 173 | 0.030 |
Why?
| Organ Size | 1 | 2017 | 434 | 0.030 |
Why?
| Combined Modality Therapy | 1 | 2019 | 1127 | 0.030 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2018 | 477 | 0.030 |
Why?
| War-Related Injuries | 1 | 2017 | 33 | 0.030 |
Why?
| DNA, Bacterial | 1 | 2017 | 309 | 0.030 |
Why?
| Sick Building Syndrome | 1 | 2015 | 4 | 0.030 |
Why?
| Dopamine | 1 | 2018 | 237 | 0.030 |
Why?
| Poverty | 1 | 2019 | 448 | 0.030 |
Why?
| Reward | 1 | 2017 | 208 | 0.030 |
Why?
| Psychological Techniques | 1 | 2014 | 7 | 0.030 |
Why?
| Environment | 1 | 2017 | 337 | 0.030 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2015 | 125 | 0.030 |
Why?
| Atomoxetine Hydrochloride | 1 | 2014 | 4 | 0.030 |
Why?
| Florida | 1 | 2014 | 73 | 0.030 |
Why?
| Community Mental Health Services | 1 | 2015 | 84 | 0.030 |
Why?
| Gene Expression | 1 | 2020 | 1436 | 0.030 |
Why?
| Body Weight | 1 | 2019 | 867 | 0.030 |
Why?
| Radiopharmaceuticals | 1 | 2015 | 187 | 0.030 |
Why?
| Risk-Taking | 1 | 2017 | 332 | 0.030 |
Why?
| Positron-Emission Tomography | 1 | 2015 | 284 | 0.030 |
Why?
| Health Surveys | 1 | 2015 | 446 | 0.030 |
Why?
| Focus Groups | 1 | 2015 | 393 | 0.030 |
Why?
| Personality | 1 | 2014 | 114 | 0.030 |
Why?
| Genome-Wide Association Study | 1 | 2019 | 1217 | 0.030 |
Why?
| Bacteria | 1 | 2019 | 729 | 0.030 |
Why?
| Exercise Test | 1 | 2015 | 539 | 0.030 |
Why?
| Pain Measurement | 1 | 2015 | 449 | 0.030 |
Why?
| Suramin | 1 | 2012 | 6 | 0.030 |
Why?
| Leukopenia | 1 | 2012 | 27 | 0.030 |
Why?
| Taxoids | 1 | 2012 | 94 | 0.020 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2012 | 83 | 0.020 |
Why?
| Phenotype | 1 | 2020 | 2831 | 0.020 |
Why?
| Health Priorities | 1 | 2012 | 34 | 0.020 |
Why?
| Infant, Newborn | 1 | 2022 | 5059 | 0.020 |
Why?
| Nausea | 1 | 2012 | 103 | 0.020 |
Why?
| Statistics as Topic | 1 | 2012 | 299 | 0.020 |
Why?
| Ethical Review | 1 | 2011 | 3 | 0.020 |
Why?
| Paclitaxel | 1 | 2012 | 192 | 0.020 |
Why?
| Wheelchairs | 1 | 2011 | 16 | 0.020 |
Why?
| Dementia | 1 | 2013 | 185 | 0.020 |
Why?
| Personal Satisfaction | 1 | 2012 | 185 | 0.020 |
Why?
| Personal Autonomy | 1 | 2011 | 39 | 0.020 |
Why?
| Disease-Free Survival | 1 | 2012 | 621 | 0.020 |
Why?
| Age Distribution | 1 | 2011 | 341 | 0.020 |
Why?
| Medical History Taking | 1 | 2010 | 114 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2012 | 724 | 0.020 |
Why?
| Neoplasm Metastasis | 1 | 2012 | 526 | 0.020 |
Why?
| Reference Values | 1 | 2011 | 744 | 0.020 |
Why?
| Geriatric Assessment | 1 | 2011 | 176 | 0.020 |
Why?
| Injury Severity Score | 1 | 2011 | 458 | 0.020 |
Why?
| Pain | 1 | 2015 | 712 | 0.020 |
Why?
| False Negative Reactions | 1 | 2009 | 50 | 0.020 |
Why?
| Self Efficacy | 1 | 2012 | 361 | 0.020 |
Why?
| False Positive Reactions | 1 | 2009 | 109 | 0.020 |
Why?
| Preoperative Care | 1 | 2011 | 318 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2012 | 1870 | 0.020 |
Why?
| ROC Curve | 1 | 2009 | 451 | 0.020 |
Why?
| Health Status | 1 | 2012 | 728 | 0.020 |
Why?
| Survival Rate | 1 | 2011 | 1650 | 0.020 |
Why?
| Physician-Patient Relations | 1 | 2011 | 465 | 0.020 |
Why?
| Activities of Daily Living | 1 | 2009 | 352 | 0.020 |
Why?
| Practice Guidelines as Topic | 1 | 2013 | 1405 | 0.020 |
Why?
| Mice | 1 | 2016 | 15052 | 0.010 |
Why?
|
|
Brenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|